Logiscreen

Qiagen NV

$42.28
Market Cap 9.17B
ROE 11.3%
Gross Margin 62.9%
Debt/Equity 0.5
Current Ratio 3.2
Revenue QoQ 1.8%
EPS QoQ -0.2%
F-Score 5

About

QIAGEN N.V., (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated instrumentation systems provides customers to transform raw biological samples into valuable molecular information.The Company serves four customer classes: Molecular Diagnostics laboratories; Applied Testing customers in fields such as forensics, veterinary diagnostics and food safety; Pharmaceutical research and development groups, and Academic researchers. The Company market its products in more than 100 countries. The Company offers more than 500 core consumable products as well as a number of instrument solutions to automate the processing of almost all QIAGEN products used for sample preparation and subsequent analysis. On May 3, 2012, the Company acquired AmniSure International LLC.

Exchange
NYSE
Sector
Healthcare
Industry
Diagnostics & Research

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
22.39
vs median 37.08
P/B
2.70
vs median 2.65
ROE
0.11
vs median 0.09

Decent quality with acceptable fundamentals

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics